Form Type: 4

SEC EDGAR Link
Accession Number:0001708138-20-000072
Date:2020-06-10
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
Original Submission Date:

Reporting Person:

ZOGHBI HUDA Y
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-06-10 M 1,706 a $391.92 2,349 direct
COMMON STOCK 2020-06-10 S 149 d $606.64 2,200 direct
COMMON STOCK 2020-06-10 S 251 d $607.64 1,949 direct
COMMON STOCK 2020-06-10 S 330 d $608.62 1,619 direct
COMMON STOCK 2020-06-10 S 161 d $609.48 1,458 direct
COMMON STOCK 2020-06-10 S 202 d $610.41 1,256 direct
COMMON STOCK 2020-06-10 S 164 d $611.46 1,092 direct
COMMON STOCK 2020-06-10 S 265 d $612.52 827 direct
COMMON STOCK 2020-06-10 S 5 d $613.03 822 direct
COMMON STOCK 2020-06-10 S 80 d $615.28 742 direct
COMMON STOCK 2020-06-10 S 99 d $616.19 643 direct
COMMON STOCK 2020-06-11 M 1,706 a $391.92 2,349 direct
COMMON STOCK 2020-06-11 S 1,706 d $625.00 643 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 391.92 2020-06-10 deemed execution date M 1,706 (d) 2026-09-09 common stock 1,706 $391.92 8,529 direct
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 391.92 2020-06-11 deemed execution date M 1,706 (d) 2026-09-09 common stock 1,706 $391.92 6,823 direct
Footnotes
IDfootnote
f1 disposition/acquisition made pursuant to a plan intended to comply with rule 10b5-1(c).
f2 represents volume-weighted average price of sales of 149 shares of company stock on june 10, 2020 at prices ranging from $606.23 to $606.94. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f3 represents volume-weighted average price of sales of 251 shares of company stock on june 10, 2020 at prices ranging from $607.02 to $607.94. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f4 represents volume-weighted average price of sales of 330 shares of company stock on june 10, 2020 at prices ranging from $608.15 to $608.9. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f5 represents volume-weighted average price of sales of 161 shares of company stock on june 10, 2020 at prices ranging from $609.31 to $609.85. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f6 represents volume-weighted average price of sales of 202 shares of company stock on june 10, 2020 at prices ranging from $610.18 to $610.63. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f7 represents volume-weighted average price of sales of 164 shares of company stock on june 10, 2020 at prices ranging from $611.06 to $611.92. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f8 represents volume-weighted average price of sales of 265 shares of company stock on june 10, 2020 at prices ranging from $612.12 to $612.90. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on june 10, 2020 at each separate price.
f9 the stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
WhaleWisdom Logo

Elevate your investments